Jun 20 |
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute Along with Funding from the Johnson Center for Cellular Therapeutics to Advance Regulatory T Cell Exosome Platform into the Clinic
|
Jun 14 |
Coya Therapeutics files to sell 603K common shares for holders
|
Jun 11 |
Coya gains as peer-reviewed data highlights potential of ALS therapy
|
Jun 11 |
Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology
|
Jun 10 |
Coya Therapeutics: Potential Milestone For The Treatment Of Alzheimer's This Summer
|
Jun 3 |
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
|
May 28 |
Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index
|
May 27 |
7 Biotech Stocks to Put on Your Breakthrough Radar
|
May 27 |
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases
|
May 23 |
Coya Therapeutics concludes Phase II Alzheimer’s therapy trial
|